Core Viewpoint - Feihe and JD.com have launched two groundbreaking products, Jicui and Qicui, marking a significant innovation in the infant nutrition sector, aimed at meeting the nutritional needs of Chinese babies and leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][3]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing core consumer demands, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when selecting infant formula [3]. - Feihe's innovation includes the first-ever integration of "fresh raw materials" into the freshness standard of infant formula, creating a closed-loop system from fresh sources to self-produced active ingredients [3][5]. Group 2: Production and Quality - Feihe has achieved self-production capabilities for 11 key raw materials, enhancing freshness by at least 23 times and demonstrating a 6.4 times improvement in absorption [5]. - The products utilize fresh raw materials produced within 30 days, significantly reducing the freshness timeline from years to days, with proprietary extraction techniques ensuring superior quality [5][10]. Group 3: Research and Development - Feihe has established one of China's largest breast milk databases and leads national initiatives in breast milk research, accumulating significant findings that inform product development [8]. - The company holds three leading positions in the industry: first in breast milk research achievements, first in infant formula patents, and first in maternal source nutrition branding [8][10]. Group 4: Clinical Validation - Feihe adheres to a "clinical first, market second" approach, conducting rigorous clinical trials before product launch, ensuring high standards of evidence for the efficacy of Jicui and Qicui [13]. - The clinical trials utilized RCT (randomized controlled trial) designs, achieving compliance with the highest global standards, thus validating the products' nutritional claims [13][16]. Group 5: Nutritional Benefits - Jicui's formula emphasizes a dual-source protective system, enhancing the baby's gut health and immune system, with evidence showing a 10.6% increase in the baby's immunoglobulin sIgA levels [10][17]. - Qicui focuses on brain development, incorporating a unique nutritional structure that mimics breast milk, leading to significant improvements in sleep patterns and cognitive development metrics [12][17]. Group 6: Market Positioning - The launch of Jicui and Qicui represents not just a formula upgrade but a strategic innovation tailored for Chinese infants, setting a new value benchmark in the infant formula industry [17]. - Feihe aims to continue providing products that support scientific nutrition, contributing to the future potential of children and the nation [17].

Core Viewpoint - Feihe and JD.com have launched two groundbreaking products, Jicui and Qicui, marking a significant innovation in the infant nutrition sector, aimed at meeting the nutritional needs of Chinese babies and leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][3]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing consumer demands for effective nutrient absorption, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when choosing infant formula [3]. - Feihe's innovation includes the first-ever integration of "fresh raw materials" into the freshness standards of infant formula, creating a closed-loop system from fresh sources to self-produced active ingredients [3][6]. - The Jicui and Qicui formulas utilize a unique low-temperature extraction process from high-quality fresh milk, achieving a freshness increase of at least 23 times and a 6.4 times improvement in nutrient absorption [6][11]. Group 2: Research and Development - Feihe has established one of China's largest breast milk databases and leads national initiatives in breast milk research, contributing to the development of new infant formulas [9][11]. - The formulas emphasize the synergistic effects of nutrients rather than just the quantity of individual nutrients, closely replicating the composition of breast milk [11][14]. - Clinical trials for the new products were conducted under strict standards, ensuring that the results are reliable and closely aligned with breast milk feeding outcomes [15][18]. Group 3: Consumer Engagement and Transparency - Feihe has introduced the industry's first "ingredient-level traceability," allowing consumers to scan QR codes on product packaging to trace the production dates of key ingredients, enhancing transparency in the supply chain [7]. - The company aims to set a new industry benchmark for self-protection formulas, demonstrating significant improvements in immune response and developmental indicators compared to traditional formulas [18]. Group 4: Market Positioning - The launch of Jicui and Qicui represents not just a formula upgrade but a commitment to providing products that are more suitable for Chinese babies, reinforcing Feihe's position as a leader in the infant formula market [18]. - The company plans to continue innovating with products and services that benefit families, ensuring that every baby can thrive under scientifically backed nutrition [18].

Core Viewpoint - Feihe has launched two innovative products, Jicui and Qicui, in collaboration with JD.com, marking a significant advancement in infant nutrition tailored for Chinese babies, leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][4]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing consumer demands for effective nutrient absorption, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when selecting infant formula [4]. - Feihe's innovation includes the first-ever integration of "freshness of raw materials" into the standards for infant formula, achieving a closed-loop system from fresh sources to self-produced active ingredients [4][6]. Group 2: Nutritional Advancements - Jicui and Qicui utilize a unique low-temperature extraction process from high-quality fresh milk, resulting in a 23-fold increase in freshness and a 6.4-fold improvement in nutrient absorption [6]. - The products are made from raw materials produced within 30 days, significantly reducing the freshness timeline from years to days, with proprietary extraction techniques enhancing the nutritional quality [6][11]. Group 3: Research and Development - Feihe has established one of China's largest breast milk databases and leads national research initiatives, accumulating significant findings that inform the development of their infant formula [12]. - The company emphasizes a holistic approach to nutrition, focusing on the synergistic effects of nutrients rather than merely increasing individual nutrient levels, effectively replicating the composition of breast milk [14]. Group 4: Clinical Validation - Feihe adheres to a "clinical first, market second" approach, conducting rigorous clinical trials to validate the efficacy of Jicui and Qicui before their market release, ensuring high standards of evidence [21]. - Clinical results indicate that infants fed with Jicui show a 38% reduction in illness rates and a 40% improvement in recovery rates compared to conventional formulas, demonstrating superior immune support [22]. Group 5: Market Positioning - The launch of Jicui and Qicui represents not just a product upgrade but a commitment to providing formulas that are more suitable for Chinese infants, setting a new benchmark in the infant formula industry [22].